The genetics of myelodysplastic syndrome: from clonal haematopoiesis to secondary leukaemia

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Nature Reviews. Cancer

• Publication date

  2016-11-11

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/nrc.2016.112PMID 27834397PMCID PMC5470392
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Faculty Opinions recommendation of Modulation of splicing catalysis for therapeutic targeting of leukemia with mutations in genes encoding spliceosomal proteins.

  2018cited by this paper
• Novel germ line DDX41 mutations define families with a lower age of MDS/AML onset and lymphoid malignancies.

  2016cited by this paper
• Spliceosomal gene mutations in myelodysplasia: molecular links to clonal abnormalities of hematopoiesis

  2016cited by this paper
• DNMT3A and TET2 compete and cooperate to repress lineage-specific transcription factors in hematopoietic stem cells

  2016cited by this paper
• Rps14 haploinsufficiency causes a block in erythroid differentiation mediated by S100A8 and S100A9

  2016cited by this paper
• The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.

  2016cited by this paper
• Somatic Mosaic Mutations in PPM1D and TP53 in the Blood of Women With Ovarian Carcinoma.

  2016cited by this paper
• Age-related mutations and chronic myelomonocytic leukemia

  2016cited by this paper
• Clinical Effects of Driver Somatic Mutations on the Outcomes of Patients With Myelodysplastic Syndromes Treated With Allogeneic Hematopoietic Stem-Cell Transplantation.

  2016cited by this paper
• BCOR regulates myeloid cell proliferation and differentiation

  2016cited by this paper
• Modulation of splicing catalysis for therapeutic targeting of leukemias with spliceosomal mutations

  2016cited by this paper
• Genomic Classification and Prognosis in Acute Myeloid Leukemia.

  2016cited by this paper
• Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes.

  2015cited by this paper
• Loss of Tifab, a del(5q) MDS gene, alters hematopoiesis through derepression of Toll-like receptor–TRAF6 signaling

  2015cited by this paper
• Inherited and Somatic Defects in DDX41 in Myeloid Neoplasms.

  2015cited by this paper
• Acute myeloid leukemia ontogeny is defined by distinct somatic mutations.

  2015cited by this paper
• Incidence and Burden of the Myelodysplastic Syndromes

  2015cited by this paper
• The RUNX family: developmental regulators in cancer

  2015cited by this paper
• Plenary Paper

  2015cited by this paper
• Lenalidomide induces ubiquitination and degradation of CK1α in del(5q) MDS

  2015cited by this paper
• Telomere dysfunction drives aberrant hematopoietic differentiation and myelodysplastic syndrome.

  2015cited by this paper
• Association Between Mutation Clearance After Induction Therapy and Outcomes in Acute Myeloid Leukemia.

  2015cited by this paper
• Germline mutations in ETV6 are associated with thrombocytopenia, red cell macrocytosis and predisposition to lymphoblastic leukemia

  2015cited by this paper
• SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts.

  2015cited by this paper
• Targeted sequencing identifies patients with preclinical MDS at high risk of disease progression.

  2015cited by this paper
• Loss of TET2 in hematopoietic cells leads to DNA hypermethylation of active enhancers and induction of leukemogenesis

  2015cited by this paper
• Combining gene mutation with gene expression data improves outcome prediction in myelodysplastic syndromes

  2015cited by this paper
• Effect of mutation order on myeloproliferative neoplasms.

  2015cited by this paper
• Isocitrate dehydrogenase 1 and 2 mutations induce BCL-2 dependence in acute myeloid leukemia

  2015cited by this paper
• Cancer-associated ASXL1 mutations may act as gain-of-function mutations of the ASXL1–BAP1 complex

  2015cited by this paper
• TET proteins and 5‐methylcytosine oxidation in hematological cancers

  2015cited by this paper
• TET2 Mutations Affect Non-CpG Island DNA Methylation at Enhancers and Transcription Factor-Binding Sites in Chronic Myelomonocytic Leukemia.

  2015cited by this paper
• Germline ETV6 mutations in familial thrombocytopenia and hematologic malignancy

  2015cited by this paper
• Cancer-Associated SF3B1 Hotspot Mutations Induce Cryptic 3' Splice Site Selection through Use of a Different Branch Point.

  2015cited by this paper
• Myelodysplastic Syndromes: Diagnosis and Treatment.

  2015cited by this paper
• Refractory anemia with ring sideroblasts and marked thrombocytosis cases harbor mutations in SF3B1 or other spliceosome genes accompanied by JAK2V617F and ASXL1 mutations

  2015cited by this paper
• SRSF2 Mutations Contribute to Myelodysplasia by Mutant-Specific Effects on Exon Recognition.

  2015cited by this paper
• WT1 recruits TET2 to regulate its target gene expression and suppress leukemia cell proliferation.

  2015cited by this paper
• Profiling of somatic mutations in acute myeloid leukemia with FLT3-ITD at diagnosis and relapse.

  2015cited by this paper
• DNMT3A in haematological malignancies

  2015cited by this paper
• Revisiting the case for genetically engineered mouse models in human myelodysplastic syndrome research.

  2015cited by this paper
• Somatic Mutations and Clonal Hematopoiesis in Aplastic Anemia.

  2015cited by this paper
• Role of chromosomal aberrations in clonal diversity and progression of acute myeloid leukemia

  2015cited by this paper
• Somatic Mutations and Clonal Hematopoiesis in Aplastic Anemia.

  2015cited by this paper
• Leukemia-Associated Cohesin Mutants Dominantly Enforce Stem Cell Programs and Impair Human Hematopoietic Progenitor Differentiation.

  2015cited by this paper
• Aberrant splicing of genes involved in haemoglobin synthesis and impaired terminal erythroid maturation in SF3B1 mutated refractory anaemia with ring sideroblasts

  2015cited by this paper
• U2AF1 mutations alter splice site recognition in hematological malignancies

  2014cited by this paper
• Inherited bone marrow failure syndromes in adolescents and young adults

  2014cited by this paper
• Cohesin in cancer: chromosome segregation and beyond

  2014cited by this paper
• Ezh2 loss promotes development of myelodysplastic syndrome but attenuates its predisposition to leukaemic transformation

  2014cited by this paper
• Identification of pre-leukemic hematopoietic stem cells in acute leukemia

  2014cited by this paper
• Investigation of 305 patients with myelodysplastic syndromes and 20q deletion for associated cytogenetic and molecular genetic lesions and their prognostic impact

  2014cited by this paper
• Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence.

  2014cited by this paper
• Preleukemic mutations in human acute myeloid leukemia affect epigenetic regulators and persist in remission

  2014cited by this paper
• Li-Fraumeni syndrome: cancer risk assessment and clinical management

  2014cited by this paper
• DNA hydroxymethylation profiling reveals that WT1 mutations result in loss of TET2 function in acute myeloid leukemia.

  2014cited by this paper
• Leptin-receptor-expressing mesenchymal stromal cells represent the main source of bone formed by adult bone marrow.

  2014cited by this paper
• Cohesin mutations in myeloid malignancies: underlying mechanisms

  2014cited by this paper
• TET2 mutations predict response to hypomethylating agents in myelodysplastic syndrome patients.

  2014cited by this paper
• Corrigendum: Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia

  2014cited by this paper
• Leukemogenesis Induced by an Activating β-catenin mutation in Osteoblasts

  2014cited by this paper
• Role of casein kinase 1A1 in the biology and targeted therapy of del(5q) MDS.

  2014cited by this paper
• Discovery and saturation analysis of cancer genes across 21 tumor types

  2014cited by this paper
• Age-related cancer mutations associated with clonal hematopoietic expansion

  2014cited by this paper
• The role of splicing factor mutations in the pathogenesis of the myelodysplastic syndromes.

  2014cited by this paper
• Somatic mutations predict poor outcome in patients with myelodysplastic syndrome after hematopoietic stem-cell transplantation.

  2014cited by this paper
• Clonal Architecture of Secondary Acute Myeloid Leukemia Defined by Single-Cell Sequencing

  2014cited by this paper
• Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo.

  2014cited by this paper
• Age-related clonal hematopoiesis associated with adverse outcomes.

  2014cited by this paper
• Cohesin and CTCF differentially regulate spatiotemporal runx1 expression during zebrafish development.

  2014cited by this paper
• Impact of molecular mutations on treatment response to DNMT inhibitors in myelodysplasia and related neoplasms

  2014cited by this paper
• Disruption of SF3B1 results in deregulated expression and splicing of key genes and pathways in myelodysplastic syndrome hematopoietic stem and progenitor cells

  2014cited by this paper
• MLL3 is a haploinsufficient 7q tumor suppressor in acute myeloid leukemia.

  2014cited by this paper
• The Role of TP53 Mutations in the Origin and Evolution of Therapy-Related AML

  2014cited by this paper
• Deep sequencing reveals stepwise mutation acquisition in paroxysmal nocturnal hemoglobinuria.

  2014cited by this paper
• Haploinsufficiency of del(5q) genes, Egr1 and Apc, cooperate with Tp53 loss to induce acute myeloid leukemia in mice.

  2014cited by this paper
• Genetic alterations of the cohesin complex genes in myeloid malignancies.

  2014cited by this paper
• Altered translation of GATA1 in Diamond-Blackfan anemia

  2014cited by this paper
• Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML.

  2013cited by this paper
• Large conserved domains of low DNA methylation maintained by Dnmt3a

  2013cited by this paper
• Landscape of genetic lesions in 944 patients with myelodysplastic syndromes

  2013cited by this paper
• BCOR and BCORL1 mutations in myelodysplastic syndromes and related disorders.

  2013cited by this paper
• Deletion 5q MDS: molecular and therapeutic implications.

  2013cited by this paper
• Role of reduced-intensity conditioning allogeneic hematopoietic stem-cell transplantation in older patients with de novo myelodysplastic syndromes: an international collaborative decision analysis.

  2013cited by this paper
• Low frequency clonal mutations recoverable by deep sequencing in patients with aplastic anemia

  2013cited by this paper
• Patterns of missplicing due to somatic U2AF1 mutations in myeloid neoplasms.

  2013cited by this paper
• CBL Linker Region and RING Finger Mutations Lead to Enhanced Granulocyte-Macrophage Colony-stimulating Factor (GM-CSF) Signaling via Elevated Levels of JAK2 and LYN*

  2013cited by this paper
• CUX1 is a haploinsufficient tumor suppressor gene on chromosome 7 frequently inactivated in acute myeloid leukemia.

  2013cited by this paper
• Signatures of mutational processes in human cancer

  2013cited by this paper
• Clonal diversity of recurrently mutated genes in myelodysplastic syndromes

  2013cited by this paper
• SETBP1 mutations occur in 9% of MDS/MPN and in 4% of MPN cases and are strongly associated with atypical CML, monosomy 7, isochromosome i(17)(q10), ASXL1 and CBL mutations

  2013cited by this paper
• Oncogenic Nras has bimodal effects on stem cells that sustainably increase competitiveness

  2013cited by this paper
• NRAS mutations with low allele burden have independent prognostic significance for patients with lower risk myelodysplastic syndromes

  2013cited by this paper
• Targeted Inhibition of Mutant IDH2 in Leukemia Cells Induces Cellular Differentiation

  2013cited by this paper
• Diminutive somatic deletions in the 5q region lead to a phenotype atypical of classical 5q- syndrome.

  2013cited by this paper
• Myeloproliferative neoplasia remodels the endosteal bone marrow niche into a self-reinforcing leukemic niche.

  2013cited by this paper
• Clinical and biological implications of driver mutations in myelodysplastic syndromes.

  2013cited by this paper
• Dynamic acquisition of FLT3 or RAS alterations drive a subset of patients with lower risk MDS to secondary AML

  2013cited by this paper
• Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia.

  2013cited by this paper
• Mutant IDH1 promotes leukemogenesis in vivo and can be specifically targeted in human AML.

  2013cited by this paper

• Evolutionary trajectories of myelodysplastic syndromes/neoplasms.

  2026cites this paper
• Catestatin ameliorates tauopathy and amyloidogenesis via adrenergic inhibition

  2026cites this paper
• A STAT3 degrader demonstrates efficacy in venetoclax resistant acute myeloid leukemia.

  2026cites this paper
• Synergistic apoptosis induction in myelodysplastic syndrome cells by azacitidine and PIM-2 inhibitors via nuclear factor-kappa B pathway inhibition

  2026cites this paper
• Circular RNA expression landscapes in myelodysplastic neoplasms: Associations with mutational signatures and disease progression.

  2026cites this paper
• Myelodysplastic syndrome progress to acute myeloid leukemia: new insights and updates.

  2026cites this paper
• Dynamic conformational ensembles of soluble Tau encode neuronal toxicity prior to aggregation

  2026cites this paper
• Potential Clinical Value of Identifying Myelodysplastic Syndrome as a Cardiovascular Risk Condition.

  2026cites this paper
• Active bone marrow dose reconstruction in a large-scale cohort study of cancer patients treated with photon radiotherapy.

  2026cites this paper
• The Link between Modifiable Risk Factors and Myeloid Disorders-From Plate to Pathogenesis.

  2025cites this paper
• X-linked sideroblastic anemia in females.

  2025cites this paper
• Molecular and cellular dynamics of measurable residual disease progression in myelodysplastic syndromes

  2025cites this paper
• ZBP1 senses spliceosome stress through Z-RNA:DNA hybrid recognition.

  2025cites this paper
• Inflammatory stromal and T cells mediate human bone marrow niche remodeling in clonal hematopoiesis and myelodysplasia

  2025cites this paper
• Haploinsufficiency of miR-143 and miR-145 reveal targetable dependencies in resistant del(5q) myelodysplastic neoplasm

  2025cites this paper
• Single-cell analysis of aplastic anemia reveals a convergence of NK and NK-like CD8+ T cells with a disease-associated TCR signature.

  2025cites this paper
• Injury-induced tau pathology promotes aggressive behavior in Drosophila without neurodegeneration

  2025cites this paper
• Detection of misfolded proteins in neurodegenerative disease models with a highly sensitive chemiluminescence probe

  2025cites this paper
• Navigating the dynamic landscape of lower-risk MDS: Advances and emerging insights.

  2025cites this paper
• Temporal dynamics of proteome and phosphorproteome during neuronal differentiation in the reference KOLF2.1J iPSC line

  2025cites this paper
• Myelodysplastic syndromes: Updates on Genomic Landscape, Molecular Subtypes, & Targeted Therapies

  2025cites this paper
• Neuronal PARIS-STAT3 axis drives tau pathology and glial activation in Alzheimer’s disease

  2025cites this paper
• Longitudinal genomic profiling of chemotherapy-related CHIP variants in patients with ovarian cancer

  2025cites this paper
• Pathological tau activates inflammatory nuclear factor-kappa B (NF-κB) and pT181-Qβ vaccine attenuates NF-κB in PS19 tauopathy mice

  2025cites this paper
• Chromatin accessibility in stem cells unveils progressive transcriptional alterations in myelodysplastic syndrome

  2025cites this paper
• IL-1R1 and IL-18 Signals Regulate Mesenchymal Stromal Cells in an Aged Murine Model of Myelodysplastic Syndromes.

  2025cites this paper
• Tubulin transforms Tau and α-synuclein condensates from pathological to physiological

  2025cites this paper
• The rewired immune microenvironment in leukemia

  2025cites this paper
• Low Allele Frequency Variants Identified on Germline Multi-Gene Panel Testing for Cancer Predisposition Can Suggest the Presence of Constitutional Mosaicism

  2025cites this paper
• Impact of Clonal Hematopoiesis on Solid Tumor Progression Following Radiation Therapy

  2025cites this paper
• Real-World Treatment Patterns, Clinical Outcomes, and Costs in Patients with Higher-Risk Myelodysplastic Syndromes Across France, Germany, and the United Kingdom

  2025cites this paper
• Potential role of miR-29b from mesenchymal stromal cell-derived extracellular vesicles in leukemic cell progression

  2025cites this paper
• An unconquered challenge in MDS: review of pathophysiology, clinical manifestations, and management options of MDS with thrombocytopenia

  2025cites this paper
• The Neurofibrillary Tangle Maturity Scale: A Novel Framework for Tangle Pathology Evaluation in Alzheimer’s Disease

  2025cites this paper
• Disruption of normal stem cell function and transmission of myelodysplastic syndrome by self-renewal of committed myeloid lineage cells

  2025cites this paper
• Oral Secondary Malignant Lesions Post-Hematopoietic Stem Cell Transplantation: A Review

  2025cites this paper
• Molecular Mechanisms of Clonal Hematopoiesis in Age-Related Cardiovascular Disease and Hematologic Malignancies

  2025cites this paper
• Hematopoietic Stem Cell Hierarchies as Novel Biomarkers of Drug Response in Myelodysplastic Syndromes and Acute Myeloid Leukemia

  2025cites this paper
• Tau pathology reprograms glucose metabolism to support glutamatergic activity and excitatory imbalance

  2025cites this paper
• MAPT Splicing Modulators as a Therapeutic Strategy for Tauopathies

  2025cites this paper
• Induced pluripotent stem cell-based modelling of disease evolution in myeloid leukemia: MDS to AML.

  2025cites this paper
• Tau Oligomerization Drives Neurodegeneration via Nuclear Membrane Invagination and Lamin B Receptor Binding in Alzheimer’s disease

  2025cites this paper
• Lesões Malignas Secundárias Orais Pós-Transplante de Células-Tronco Hematopoiéticas: Uma Revisão

  2025cites this paper
• An inflammatory T-cell-stromal axis contributes to hematopoietic stem/progenitor cell failure and clonal evolution in human myelodysplastic syndrome

  2025cites this paper
• RNA modifications in health and disease: from mechanistic insights to therapeutic applications

  2025cites this paper
• Pandora’s Box of AML: How TP53 Mutations Defy Therapy and Hint at New Hope

  2025cites this paper
• Functional Dissociation in the Developing Superior Temporal Lobe: Language and Theory of Mind

  2025cites this paper
• Allogeneic Transplantation for Older Adults.

  2025cites this paper
• Comparative Analysis of IPSS, IPSS-R, and WPSS for Predicting Survival and Leukemic Transformation in Myelodysplastic Neoplasms: A Real-World Single-Center Experience

  2025cites this paper
• Analyses of exon 4a structure reveal unique properties of Big tau

  2025cites this paper
• Clonal hematopoiesis of indeterminate potential: contribution to disease and promising interventions

  2025cites this paper
• Clonal hematopoiesis at the crossroads of Inflammaging and cardiovascular disease: Mechanistic insights and translational horizons

  2025cites this paper
• Multifaceted functions of the Wilms tumor 1 protein: From its expression in various malignancies to targeted therapy

  2024cites this paper
• Unmasking Vitamin B12 Deficiency Misdiagnosed as Myelodysplastic Syndrome

  2024cites this paper
• Understanding human oncogene function and cooperativity in myeloid malignancy using iPSCs.

  2024cites this paper
• Myelodysplastic syndromes among atomic bomb survivors in Nagasaki: similarities to and differences from de novo and therapy-related cases

  2024cites this paper
• Advancements in pseudouridine modifying enzyme and cancer

  2024cites this paper
• Prognostic impact of next-generation sequencing on myelodysplastic syndrome: A single-center experience

  2024cites this paper
• Molecular Pathology of Mature Lymphoid Malignancies.

  2024cites this paper
• Clonal hematopoiesis of indeterminate potential and cardiovascular disease: Pathogenesis, clinical presentation, and future directions.

  2024cites this paper
• Distinct characteristics of lymphoid and myeloid clonal hematopoiesis in World Trade Center first responders

  2024cites this paper
• Next generation sequencing reveals the mutation landscape of Chinese MDS patients and the association between mutations and AML transformations

  2024cites this paper
• 髓系肿瘤伴大颗粒淋巴细胞增殖的临床特征研究

  2024cites this paper
• Detection and interpretation of clonal hematopoiesis variants during routine solid tumor next-generation sequencing: a single institution experience.

  2024cites this paper
• Genomic ascertainment to quantify prevalence and cancer risk in adults with pathogenic and likely pathogenic germline variants in RASopathy genes

  2024cites this paper
• The DNA methyltransferase inhibitor 5-aza-4'-thio-2'-deoxycytidine induces C>G transversions and acute lymphoid leukemia development.

  2024cites this paper
• BRAF Mutations in Patients with Myeloid Neoplasms: A Cancer Center Multigene Next-Generation Sequencing Analysis Experience

  2024cites this paper
• Multi-omic phenotyping of iPSC-derived neurons harboring the MAPT V337M mutation reveals tau hypophosphorylation and perturbed axon morphology pathways

  2024cites this paper
• Age barriers in allogeneic hematopoietic cell transplantation: Raising the silver curtain

  2024cites this paper
• Genome and clonal hematopoiesis stability contrasts with immune, cfDNA, mitochondrial, and telomere length changes during short duration spaceflight

  2024cites this paper
• The evolution of preclinical models for myelodysplastic neoplasms

  2024cites this paper
• INTEGRAL‐ILCCO cohort data analysis revealed the association of clonal haematopoiesis with an increased risk of lung cancer

  2024cites this paper
• Applications of Circulating Tumor DNA in Myelodysplastic Syndromes and Acute Myeloid Leukemia: Promises and Challenges.

  2024cites this paper
• Identification of novel myelodysplastic syndromes prognostic subgroups by integration of inflammation, cell-type composition, and immune signatures in the bone marrow

  2024cites this paper
• Clonal hematopoiesis and inflammation in the vasculature: CHIVE, a prospective, longitudinal clonal hematopoiesis cohort and biorepository

  2024cites this paper
• Acetylation mimetic and null mutations within the filament core of P301L tau have varied effects on susceptibility to seeding and aggregation

  2024cites this paper
• Aging and cancer

  2024cites this paper
• MDS and AML show elevated fractions of CD34-positive blast cell populations with a high anti-apoptotic versus proliferation ratio.

  2024cites this paper
• CRISPR screens in mechanism and target discovery for AML

  2024cites this paper
• Comprehensive Analyses of the Effects of the Small-Molecule Inhibitor of the UHM Domain in the Splicing Factor U2AF1 in Leukemia Cells

  2024cites this paper
• Predicting which subsets of patients with myelodysplastic neoplasms are more likely to progress to overt chronic myelomonocytic leukemia

  2024cites this paper
• The potential of RNA methylation in the treatment of cardiovascular diseases

  2024cites this paper
• Inherited blood cancer predisposition through altered transcription elongation.

  2024cites this paper
• Updates in biology, classification, and management of acute myeloid leukemia with antecedent hematologic disorder and therapy related acute myeloid leukemia.

  2024cites this paper
• ZBP1 activation triggers hematopoietic stem and progenitor cell death resulting in bone marrow failure in mice

  2024cites this paper
• RNA binding protein‐directed control of leukemic stem cell evolution and function

  2024cites this paper
• Hyperactivation of NF-κB signaling in splicing factor mutant myelodysplastic syndromes and therapeutic approaches.

  2024cites this paper
• Influence of FTDP-17 mutants on circular Tau RNAs

  2023cites this paper
• Crosstalk between DNA methylation and hypoxia in acute myeloid leukaemia

  2023cites this paper
• Acute Myeloid Leukemia Arising from Myelodysplastic Syndromes.

  2023cites this paper
• Chrysin a promising anticancer agent: recent perspectives

  2023cites this paper
• Targeted NGS on sequential bone marrow biopsies aids in the evaluation of cytopenias and monocytosis and documents clonal evolution—a proof of principle study

  2023cites this paper
• Identification of lysosomal genes associated with prognosis in lung adenocarcinoma

  2023cites this paper
• Upregulation of S100A6 and its relation with CD34+ cells apoptosis in high-risk myelodysplastic syndromes patients

  2023cites this paper
• Depletion of tet2 results in age-dependent changes in DNA methylation and gene expression in a zebrafish model of myelodysplastic syndrome

  2023influential citation
• Deciphering the mitophagy receptor network identifies a crucial role for OPTN (optineurin) in acute myeloid leukemia

  2023cites this paper
• An accessible patient-derived xenograft model of low-risk myelodysplastic syndromes

  2023cites this paper
• Improved Protocol for Reproducible Human Cortical Organoids Reveals Early Alterations in Metabolism with MAPT Mutations

  2023cites this paper
• The bone marrow stroma in human myelodysplastic syndrome reveals alterations that regulate disease progression

  2023cites this paper
• Progressive disruption of hematopoietic architecture from clonal hematopoiesis to MDS

  2023cites this paper